epidermolysis bullosa, junctional
Showing 1 - 5 of 5
Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa, Junctional Trial in Paris (CACIPLIQ20, Placebo)
Not yet recruiting
- Epidermolysis Bullosa Dystrophica
- Epidermolysis Bullosa, Junctional
- CACIPLIQ20
- Placebo
-
Paris, FranceHopital Necker - enfants malades
Aug 17, 2023
Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica Trial in Worldwide (INM-755
Recruiting
- Epidermolysis Bullosa Simplex
- +3 more
- INM-755 (cannabinol) cream
- Vehicle Cream
-
Salzburg, Austria
- +6 more
Mar 30, 2022
Computational Drug Repurposing for All EBS Cases
Recruiting
- Epidermolysis Bullosa
- +5 more
- Experimental Group
-
Palo Alto, CaliforniaPediatric Dermatology Clinic at Stanford Children's Hospital
Jan 11, 2022
The State of Sexual Development in Inherited Epidermolysis
Active, not recruiting
- Dermatologic Disease
- +7 more
- Biochemical study of hormone levels
- +3 more
-
Moscow, Russian FederationNational Medical Research Center for Children's Health
Aug 26, 2021
Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica Trial in United States (Apligraf, Standard dressing
Terminated
- Epidermolysis Bullosa, Junctional
- Epidermolysis Bullosa Dystrophica
- Apligraf
- Standard dressing regimen
-
Stanford, California
- +4 more
Jun 25, 2010